Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Bayer and PPL place hold on recombinant alpha1-antitrypsin development project

June 20, 2003

Reduced nasal obstructive response to allergen after pretreatment with CAT-213

June 20, 2003

Specific human mast cell tryptase inhibitor blocks collagen production in human lung fibroblasts

June 19, 2003

ORL1 receptor agonists and their use as antitussives, analgesics, anxiolytics, etc.

June 18, 2003

New series of chemokine CCR3 receptor modulators identified at BMS

June 17, 2003

Morphochem presents new tryptase and uPA inhibitors

June 17, 2003

Adenosine A2B receptor antagonists with utility in asthma, diarrhea, etc.

June 16, 2003

Three series of PDE4 inhibitors and their use claimed by Tanabe Seiyaku researchers

June 16, 2003

Enrollment concluded in supportive phase III trial of Surfaxin for RDS

June 10, 2003

Baxter launches Aralast

June 5, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...